Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study
Clinical trial NCT03617666 · UNKNOWN
Trial details
- NCT number
- NCT03617666
- Sponsor
- University College, London
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-27
- Primary completion
- 2022-07-04
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.